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Within the 12 Member States ofthe European Community (EC), environmental policy is now formulated
primarily atCommunitylevel.As aresult,the EC has importantregulatoryresponsibilities fortheprotection
of workers, consumers, and the general public from risks that may arise from environmental chemicals,
foremost amongthempotentialcarcinogens and mutagens.An importantpartofEC environmental research
and development is intended to provide a scientific basis for these regulations as well as increasing
understanding of the basic mechanisms involved in environmental carcinogenesis and mutagenesis. This
paper contains a brief introduction to EC environment policy and research, followed by an overview of EC
chemicals control activities that are of particular relevance to the research and development program.
Community-level research on environmental mutagenesis andcarcinogenesis is then reviewed in some detail,
including the achievements ofrecent projects, the scientific content ofthe current program, and perspectives
for the future.
Introduction
Theprotection ofthe environmentandthequalityoflife
are ofthe highest political and public interest. The Euro-
pean Community's (EC) first Action Programme on the
Environment was agreed on in 1973. With the signing of
the European Single Act in 1987, the Community was
given significant new responsibilities for environmental
protection. It is fair to say that environmental policy and
regulation is now primarily carried out at Community,
ratherthan atMember Statelevel. Bynow, there aremore
than 200 pieces of EC legislation on the environment,
covering pollution of the atmosphere, water, and soil,
waste management, safeguards in relation to chemicals
and biotechnology, product standards, environmental
impact assessments, and the protection ofnature.
Overthese last20years or so,there hasbeen adiscern-
ible shift in EC environment policy away from reactive
measures to combat acute environmental pollution prob-
lems toward increasingly broad-scale and preventive
approaches. For example, when Community industrial,
agricultural, transport, energy, and regional development
policies are now formulated, their likely implications for
the environment are assessed. The Community has also
clearlyunderlinedits commitment toenvironmentally sus-
tainable development.
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European Community Research and
Development-on Environmental
Protection
The Single European Act stipulates that: "in preparing
its action relating to the environment, the Community
shall take account of available scientific and technical
data." EC-level research and development ofthe environ-
ment has the following broad objectives: a) to provide
scientific and technical data that support the Community
Environment Policy, b) to address longer-term environ-
mentalproblems in supportofpreventive and anticipatory
policies, c) to serve as an instrument for enhancing fur-
ther, at Community level, the coordination of research
activities in the environmental field.
EC environmentalresearchisbasicallyimplemented by
in-house research and development (R&D) or by shared-
cost contract R&D. The former is carried out at the Joint
Research Centre's Environment Institute in Ispra, Italy.
R&D on environmental chemicals is an important part of
the Institute'swork, and alsoincludes the operation ofthe
Environmental ChemicalsDataand InformationNetwork.
Shared-cost contract R&D in the environment field is
managed by the Environment Research Division of the
Commission's Directorate General for Science, Research
and Development (DG XII), and this is the subject ofthis
article.TheresourcesprovidedforEC contractR&Dhave
increased substantially in recent years; this reflects the
high priority given to environmental issues by MemberA L SORS
States, and recognition ofthe crucial role ofresearch and
development in tackling these issues. The current
Environment R&D program (STEP and EPOCH, 1989-
1992) have an allocation of 115 MECU (1 MECU = 1
million ECU. 1 ECUis approximately1.35in U.S. dollars);
the new EC Environment R&D Programme (1991-1994)
has abudgetof260 MECU. Contracts are awarded on the
basis ofcompetitive research applications in response to a
public call for proposals. Projects must be transnational,
with partners from at least 2 EC Member States. The
average project has about 5 partners, although in some
cases many more are involved.
In addition to the twelve EC Member States, Sweden,
Norway, Finland, and Austria participate fully in this
Programme. Institutes from other European countries
can participate on a project-by-project basis; however, at
present, their participation cannot be supported by Com-
munity funds. There is intensive competition for EC
research funding; on average only about one in eight
proposals can be financed.
EC environmental R&D programs cover the whole
spectrum ofenvironmental issues, including mechanisms
andimpacts ofglobalchange,inparticularclimatechange
and depletion of stratospheric ozone; clean technologies,
waste management, industrial accidents, protection of
cultural items; socioeconomic environmental research;
and natural and technological risks, includingresearch on
genetic effects ofchemicals and onbiomonitoring ofpopu-
lations exposed to genotoxic substances.
Control of Environmental Chemicals
in the European Community
As mentioned in the previous section, a primary objec-
tive of EC environmental R&D is to provide a sound
scientific basis for EC environmental policy. Research on
genetic effects of chemicals and on biomonitoring tech-
niquesforgenotoxic substances isintendedtosupportthis
policy, particularly in relation to the control of chemical
substances.
The overall aim ofchemical control by the EC has been
to develop comprehensive legislation to harmonize pro-
cedures and standards in such a way as to allow free
circulation of goods and encourage industrial com-
petitivityandtechnologicaldevelopmentwhile, atthe same
time, ensuring a high level ofprotection for man and for
theenvironment. Several complementary approaches have
beenadopted.Theseincludedirectives ontheclassification
and labeling ofdangerous chemicals, the systematic eval-
uation ofexisting chemicals, protection ofanimals used in
testing, protection ofworkers, etc.
Classification and Labeling ofNew
Chemicals
Classification and labeling was the first EC chemicals
directive, adopted in June 1967, and amended since seven
times. The Sixth Amendment, agreed on in 1979, carried
themostsignificantchange,requiringmandatorynotifica-
tion of new chemical substances 45 days before they are
placed onthemarket. It was oneofthefirsttruly"preven-
tive" rather than "curative" EC environmental actions.
The evaluation required for notification is carried out on
the basis of data presented in the notification dossier,
which consists of four elements: a) a technical dossier
supplying the information necessary for evaluating the
foreseeable risks, whether immediate or delayed, that the
substance may entail for man and the environment, b) a
declaration concerning the unfavorable effects ofthe sub-
stance in terms of the various uses envisaged, c) the
proposed classification and labeling of the substance in
accordancewiththe directive, d)proposals for any recom-
mended precautions relating to the safe use of the sub-
stance.
Thetechnicaldossieris definedinAnnexVII ofthe1979
Directive and includes information about theidentity, use,
quantities, and disposal of the substance, as well as the
basic physicochemical, toxicological, and ecotoxicological
test results. For genotoxicity testing, the requirements
are indicated in Table 1. Requirements vary according to
the quantities marketed per year. To ensure harmoniza-
tion at the testing level, Annex V ofthe Directive clearly
specifies the test methods to be used.
Systematic Evaluation ofExisting
Chemicals
The EC had been notified of around 600 new chemical
substances (by March 1991). However, there are over
100,000 chemicals that were placed on the market before
the notification scheme came into force in September
1981-these are the "existing chemicals." The European
Inventory of Existing Commercial Chemical Substances
(EINECS) includes, for each substance, its EINECS
number,chemical name,itsmolecularformula, andits CAS
number. On the basis of current knowledge, production
quantites, structure-activityrelationshipapproaches, etc.,
alist ofabout25 substances is to be established each year
forpriorityattention.Ariskassessmentwillbecarriedout
on these chemicals and the possible needs for regulatory
action considered.
Table 1. EC Council Directive 79/831/EEC (Sixth Amendment).
Testing for genetic toxicity
Level 0 Technical dossier (AnnexVII)
1-10 tons/year (Base set)
Two tests Gene mutation test inS. typhimurium orE. coli
Chromosomalaberrationtestinmammaliancells
(in vitro) or the micronucleus or the meta-
phase analysis ofbone marrow cells (in vivo)
Level 1
10-100 tons/year Optional
>100 tons/year Obligatory
Four tests Two tests ofthe base set plus
Gene mutation test in eukaryotic cells
Chromosomalaberrationtest(invivo orinvitro)
Level 2
>1,000tons/year Long-term carcinogenicity
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Protection ofWorkers
Community directives concerning protection against
the effects of chemicals in the workplace are of general
application across the spectrum ofindustry from produc-
tion to placement on the market to final disposal. These
actions are based primarily on two framework directives.
Three types of control may be introduced: a) for highly
dangerous agents ofthe type industrial society could and
should dispense with, a ban on production and use (e.g.,
certain amines); b)forotherhighlydangerous agents (e.g.,
carcinogens) that cannot reasonably be banned, highly
effective worker protection systems using, wherever
possible, ofclosed systems; c) for other dangerous agents,
a monitoring system based, inter alia, on exposure limit
values.
Other Relevant Measures
There aretwo other EC directives thatareofparticular
relevance to EC R&D on genetic effects ofchemicals. One
is the "Seveso Directive" of1982 concerning major indus-
trial hazards ofcertain industrial activities. The directive
contains agreed-on minimum requirements on preventive
measures atthe stage ofplant orprocess design; installa-
tion ofcontrol and safetymeasures aswell as preparation
of emergency plans; and control ofmajor industrial acci-
dents (if they occur) including sharing information con-
cerning the causes, emergency, medium, and long-term
measures adopted, and the extent ofdamage.
Finally,theCommunityhasrespondedtopublicconcern
abouttheuse ofanimals intesting: in1986 aDirectivewas
adopted concerning the "approximation of laws, regula-
tions, etc., regarding the protection of animals used for
experimental and other scientific purposes." In recogni-
tionofthe needsforscientificprogress inthisfield, in1991,
the Commission has established a European Centre for
theValidation ofAlternative Methods, to be located atthe
EC's Joint Research Centre in Ispra, Italy.
During the next 10 years, the EC will continue to
improve control ofenvironmental chemicals. Some signifi-
cant, planned initiatives are outlined in Table 2.
Scientific Content of EC R&D on
Genetic Toxicity
Cooperative R&D on the genetic effects ofenvironmen-
tal chemicals has been a feature of EC environmental
R&D for more than 15 years. During earlier programs,
numerous test systems using bacteria, fungi, cultured
cells, Drosophila, and whole animals have been studied,
involving comparative assessments bytheuse ofreference
mutagens. The results obtained were ofdirect application
in the definition of test protocols incorporated in the
Annexes to the Sixth Amendment and in the overall
database onthevalidity ofshort-term tests. Thefollowing
sections contain an overviewofsomepast R&D programs,
an outline of current work, and discussions of future
perspectives.
Table 2. Planned initiatives ofthe European Community.
Data collection Effective notification procedure for all chemi-
cals
Hazard identification Maintenance/improvement of existing classifi-
cation criteria
Risk assessment Common principles for assessments
Assessment of high production volume chemi-
cals
Assessment of active substances in non-
agricultural pesticides
Risk management Strengthens links between classification and
control measures
Risk reduction Risk reduction programs for selected priority
chemicals.
Some Achievements ofthe Previous R&D
Programs
Inthis section,someofthemainachievementsofthetwo
previous R&D programs in this field are reviewed. These
were the Third Programme (1981-1985) and the Fourth
Programme (1986-1990). Detailed scientific reviews ofthe
former have been published (1,2).
The overall scientific output of the Third R&D Pro-
gramme was examined by a bibliographic survey, which
was commissioned by an independent evaluation panel.
This survey found that in all areas covered by the R&D
program ongeneticeffectsofenvironmentalchemicals,the
number ofpublished papers in qualitypeer-reviewedjour-
nals, as aproportion oftotal European andworld outputs,
was far in excess of its relative size in terms of financial
and manpower resources.
Correlations between Mutagenicity Tests and Other
Assays for Carcinogenic Potential. The observed cor-
relation between the ability ofa chemical to induce muta-
tion in various test systems and its carcinogenic potential
hasprovidedmuchoftheincentivefortestsystemdevelop-
ment. The Third Programme focused on cell transforma-
tion methods as potential assays for carcinogens. Results
indicated that transformation assays provide models for
the progressive stages of tumour induction and develop-
ment. This was further developed during the Fourth
Programme as assays for nongenotoxic or epigenetic car-
cinogens.
Host-mediated Assay The host-mediated assay in-
volves use of indicator bacteria injected into a small
rodent. Indicatorspecies arethenusedtodeterminemuta-
genic effects of a chemical given to rodents. The project
identified manyvariables in this assay such as the effects
of rodent strain, age of rodent, and effects of diet. This
assayhas to some extentbeenbypassedbynewertechnol-
ogies suchasmeasurementofunscheduledDNAsynthesis
(UDS) in specific tissues, transgenic animals, and direct
measurement of DNA base changes.
UDSin CulturedMammalian Cells. Here, the princi-
pal result ofthe Third Programme was an understanding
oftheimportanceofthemeasurementofDNAsynthesisin
the nucleus and in the cytoplasm. Further development of
this assay for use in the liver of the rat has provided an
important regulatory method.
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Metabolic Activation. In the Third Programme, vari-
ables examined included inducers of P450, growth condi-
tions to improve activation potential by yeasts, rodent
strain differences, and constituents of S-9 mix. In the
Fourth Programme, this project was broadened into the
development and validation of metabolic activation sys-
tems in mutagenicity testing that are not derived from
animals.
Mutagenicity of Aerosol Extracts. The aim of this
work was to produce a mutagenic fingerprint of aerosol
samples, to characterize thepotential genotoxicityofeach
component, and to assess the overall mutagenicity ofthe
mixture. The studies indicated that the samples contain
genotoxic chemicals. However, thework was less success-
ful inidentifyingthe specific constituents ofthe genotoxic
extracts and the overall mutagenic profile ofthe samples.
Transplacental Genotoxicity* The mammalian trans-
placental assaysystemwasdevelopedtothestagewhereit
can be used to investigate differential sensitivity of the
fetus to specific environmental chemicals. The sensitivity
of specific stages of fetal development may be assessed,
and the effects of modifiers of metabolic activity can be
determined.
Aneuploidy The Third Programme demonstrated that
alargenumberofchemicalsinduceaneuploidyinfungi.At
the same time, several questions arose in relation to the
relevance of this system to man-for example, whether
fungi can be used to screen aneugens and whether a suit-
able regulatory assay can be developed. In continuingthis
work, the Fourth Programme showed that fungi are not
suitable for screening, and further evidence was obtained
of the complex mechanisms by which chemicals induce
aneuploidy, as well as confirmation that aneuploidy is
important in tumor development.
Developmentand Validation ofAnimal Tests. Animal
tests are essential for labeling mutagens. Comparisons of
several tests were performed, including specific locus,
bone marrow cytogenetics, specific-tissue UDS, mouse
spot test (in embryos), dominant lethality, germ cell
cytogenetics, and tumor promotion. This work underlined
the need to apply new technologies to improve resolution
and quality and to reduce animal usage.
Drosophila. Assay systems using the fruit fly, Dros-
ophila melanogaster, allowthe detection ofawider range
ofgeneticendpoints, studyofsomatic andgermcells, and
study of the biotransformation of many chemicals. The
studieshave demonstrated thevalue ofthis systemforthe
genotoxic assessment ofenvironmental chemicals. Anota-
bleachievementwasthedevelopmentoftheSMARTsoma-
tic assay, which may provide information for specific
purposes.
Development of New Technologies. The development
andapplication ofnewtechnologies hasbeen animportant
feature oftheprograms. Examplesincludea)development
and use of specific monoclonal antibodies; b) molecular
probes for detecting specific DNA sequences; c) new
molecular approaches to measure DNA base changes in
exposed cells in vitro and in vivo.
Molecular Dosimetry The purpose of the molecular
dosimetry project is to study the possibilities of using
DNA adduct formation as a parameter for comparative
studies. Model chemicals used were a series ofethylating
agents. Genetic effects in different assay systems (E. coli,
Drosophilia, cultured mammalian cells, mouse germ cells)
were compared and DNA adduct frequencies were deter-
mined.
Duringthe firstperiod (1982-1985), the technologywas
developed and the initial experiments were carried out,
showing that in fast-growing cells the induced mutant
frequencies were the same for all ethylating agents when
compared at equal frequencies of 06-ethylguanine. This
suggests that most of the genetic effect induced by the
ethylating agents is caused by the DNA adduct O6_
ethylguanine. Thisobservationwasfollowedupinthenext
program (1986-1990) by carrying out experiments using
methylating agents. The data in germ cells ofmice show
thatthere is a strong specificity ofmutation induction for
specific stages ofgermcells. The data also suggestthatin
germ cells the 06-alkylguanine adduct is not the muta-
genic lesion. More recently, molecular techniques have
been developed that allowed DNA sequencing ofinduced
mutations. Thisapproach showedthatingrowingcellsthe
majority ofthe mutants induced by ethylating agents are
atGCbasepairs,whereasinmouse germcells all mutants
analyzed are at AT base pairs.
Biomonitoring Human Populations Exposed to En-
vironmental Genotoxic Chemicals. This project,
launched by the Commission in 1988, is intended to assist
the development of population monitoring systems
designed to quantify the exposure to potential mutagenic
chemicals in the environment and to detect possible early
effects. During the last decade, great progress has been
made in methodologies for assessing exposure to and
biological effects ofgenotoxic chemicals. Newmethods for
the identification of DNA damage in vivo offer the pos-
sibility to quantify individual exposure.
In the first phase, the Biomonitoring Project consisted
of the development, comparison, and intercalibration of
advanced techniques for the quantification ofa molecular
(target)doseanditscomparisontoexternalexposure. The
approach is based on the measurement of DNA and pro-
tein adducts in relation to selected genetic end points.
Eleven laboratories from eight European countries
cooperated closely on various aspects of methodological
development, for a) the identification and measurement of
DNA adducts by32P-postlabeling method, immunological
assays, andadvancedmass spectrometrytechnique; b)the
detection of hemoglobin and plasma protein adducts by
gas chromatography-mass spectrometry; c) the detection
of chromosomal aberrations, sister chromatid exchanges,
and micronuclei in peripheral lymphocytes; d) the quan-
titative determination of hprt mutant frequency in lym-
phocytes and mutations in hemoglobin gene. A detailed
review ofthis coordinated project has recently been pub-
lished (3).
The Current R&DProgram
Work within the current program began in the latter
part of 1991. There are 11 coordinated projects, involving
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about60research institutions in14 European countries. A
brief synopsis of each coordinated project is provided
below.
Detection and Evaluation ofAneugenic Chemicals.
The aimofthisprojectis toincreaseunderstandingofthe
effects of aneugenic chemicals in cultured mammalian
cells, rodent bone marrow, and rodent germ cells and, on
thisbasis, developexperimentalsystemscapableofdetect-
ing and assessing environmental aneugens.
Nongenotoxic Carcinogens: Development of Detec-
tion Methods Based on Mechanisms. This project will
investigate to what extent fibroblast transformation sys-
tems and inhibition ofgapjunctional intercellular commu-
nication in established cell lines can detect nongenotoxic
carcinogens. The possibility of using other proposed
mechanisms ofnongenotoxic carcinogenesis to develop as
assays will also be evaluated.
Development and Validation ofMetabolicActivation
Systems for Mutagenicity Testing Not Using Verte-
brate Animals. This project aims to develop reliable in
vitro systems to detect mutagenicity ofindirectly acting
mutagens/carcinogens. Theworkwillincludevalidation of
cell lines capable ofmetabolizing mutagens (e.g., Hep G2,
CHEL, V79/Cyt450, PHH); preparation of microsomal
extracts ofthe above to act as exogenousmetabolic activa-
tionsystems;validationofplantactivation systems, aswell
as hemoglobin and biomimetric-based metabolic systems.
Detection of Germ Cell Mutagens. The goal of this
projectis to improve recognition ofgerm cell mutagens in
chemical substances andinthe environment. Tests such as
themousespecificlocus,heritabletranslocation assay, and
dominantlethalareappliedtoidentifygermcellmutagens.
New methodologies such as spermatid micronucleus test
and flow cytometry of sperm-DNA are validated against
data from the former. A database on germ cell muta-
genecity will also be established.
Somatic Recombination, Gene Amplification, and
Cancer. Genetic recombination, gene amplification, and
transposition may be of importance in tumor formation.
This projectwill provide information on the occurrence of
chemicals that may act as recombinogenic agents and
inducers of recombination-related end points such as
transpositions and gene amplification. The data obtained
mayalsoreveal systematicrelationshipsbetweenchemical
structure and recombinogenic activity.
DevelopmentofNewMethods forDetectionofGenetic
Alterations in Man. This project is intended to develop
molecularmethods thatcan detectmutations in anycell or
organ ofexposedindividuals orexperimental animals. The
techniques should identify alterations at any chosen
restriction site in a gene ofinterest. The specific objective
ofthis project is to solve the main technical problems and
to validate the approach in a limited number of test
systems using different organisms.
Implications ofStructure-ActivityRelationships for
Cross-Species Extrapolation in Mutagenesis and Car-
cinogenesis. The overall objective of this project is to
develop risk assessment procedures for groups of struc-
turally related chemicals. In this project, three groups of
chemicals are to be analyzed; alkylating agents, cross-
linking agents, and N-substituted aryl compounds. The
workwillattempttoelucidatecorrelationsbetweenchemi-
calreactionparameters, reactivitywithDNA,thetypes of
genetic damageproduced, and theposition ofeach chemi-
cal on the "relative carcinogenic potency" scale.
MolecularDosimetryofChemicalMutagens. Theaim
ofthis projectis to continue investigations ofwhether the
frequency of DNA adducts in the target cells or target
tissues canfunction as ameasure ofexposure onthebasis
ofwhichthemagnitudeofgeneticeffectsindifferentassay
systems can be interrelated. In this project, DNA adduct
frequencyas afunction ofthe exposure concentration ofa
series of mutagens will be determined in a number of
organisms inwhich the induction ofgenetic effects is also
measured.Analysisofthepersistence oftheDNAadducts
and molecular analysis ofthe genetic effects at the DNA
levelwill allow determination ofthe type ofDNAadducts
responsible for the observed genetic changes.
Biomonitoring Human Exposure to Environmental
GenotoxicChemicals. Theoverallobjectiveofthisproject
is to determine the additional genetic burden carried by
individuals exposed to urban pollution. Samples will be
collected from populations in urban locations. Physico-
chemical methods will be developed to assay adducts
formed by aromatic compounds, low molecular weight
alkylating agents, and radical DNA-damaging agents.
Mutation and cytogenetic analysis will also be performed.
Results will be compared with those from populations in
industrial surroundings (positive control) and in rural
locations (negative control). The biomonitoring methods
will be compared for their relative sensitivity and
applicability for exposure monitoring.
Biomonitoring Populations Exposed to Pesticides.
Biomonitoring methodswill be applied to evaluate profes-
sional exposure to arange ofcommonlyused pesticides in
parts ofItaly, Spain, and Finland. Biological assays to be
used include chromosome aberrations; sister chromatid
exchanges; micronuclei; poly(ADP-ribose)polymerase;
urine analyses; and cholinesterase. Chemical methods
include DNA adducts; hemoglobin-amino acid adducts;
and plasma protein adducts.
Assessment ofHuman Exposures to Butadiene as a
Model for Risk Estimation of Petrochemical Emis-
sions. Butadieneis animportantindustrialchemical and a
frequent contaminant in traffic exhausts, ambient air,
drinking water, and tobacco smoke. This project will
includecomparisonsbetweenenvironmentalandbiological
monitoringmethods,betweencytogeneticeffectsandmac-
romolecularbinding, andbetween adductlevels ofoccupa-
tionally and environmentally exposed individuals. This
workwill entail development and'validation ofbiomonitor-
ing techniques and hazard estimation approaches for
human cancer.
Supporting Activities
The significant EC research effort is supported by
various activities intended to enhance its efficiency, to
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maximize the added value ofinternational cooperation, to
assist dissemination of results, and to increase the rele-
vance ofthe work to environmental and health protection
policies. The scientists participating inthisprogrammeet,
at least once each year, in contact group meetings. Here,
progress is discussed, future directions agreed on, and
newcollaborative activitiesinitiated. Each suchmeetingis,
in turn, hosted by a different participating institution.
In some cases, the Commission participates inthe orga-
nization ofinternational workshops, symposia, etc. In this
particular researchfield, organizational andfinancial sup-
port has been provided for recent annual meetings ofthe
EEMS(European Environment Mutagen Society) andfor
a number of meetings hosted by IARC (International
Agency for Research on Cancer) and ICPEMC (Interna-
tional Commission for Protection Against Environmental
Mutagens and Carcinogens).
Finally, followingtheinvitation ofthe OECD Chemicals
Division, the Environment Research Programme acted as
"lead country" in preparing the detailed review paper to
revise OECD Guidelines forGenetic ToxicityTesting. This
task was entrusted to three participants in the program
(A. Carere, G. Mohn, J. Parry), who prepared the detailed
reveiw paper in close consultation with other scientists in
the EC program.
Future Perspectives
Within the new EC Environment R&D Programme
(1991-1994), work in this area will continue to provide
direct support for Community policies related to the
screening, health risk assessment, and control ofenviron-
mental chemicals. This includes short-term support
through improvement ofpredictive testing ofspecific end
points related particularly to carcinogenic and mutagenic
risk and long-term research to elucidate the basic mecha-
nisms of environmental carcinogenesis and mutagenesis.
There are two main research themes, as discussed below.
Further Development of Genetic Tbxicity Testing.
Research will include further refinement and, where
appropriate,validation oftests forestablished genetic end
points, which are suitable for incorporation into existing
regulatory protocols, as well as development of novel
approaches and techniques to increase coverage of end
points that may be associated with genetic disease and
cancer. Particular emphasis is given to innovations that
allow reduction in the use of animals in testing without
detriment to predictive capability.
Relating Genetic Toxicity to Cancer and Heritable
Mutations. In addition to improving the scientific and
technicalbasis ofregulatoryschemesforgeneticeffectsof
chemicals,itisalsointendedtoimproveourunderstanding
of the mechanisms by which exogenous agents may be
involved in the etiology of cancer and mutations in man.
This will facilitate prevention and risk assessment and
lead to significantly more effective and efficient chemicals
testing strategies.
Application to Urgent Environmental
Problems
The research undertaken in this R&D Programme
clearly requires highly advanced manpower and technical
resources. However, as well as providing both immediate
and longer-term support for European Community
environmental and health policies, it is intended that the
work should be ofimmediate relevance to urgent environ-
mental health problems. For example, there may be
increasedhazards associatedwithelevatedlevels ofpoten-
tially mutagenic or carcinogenic pollutants in various
parts of Eastern and Central Europe. The European
Community is actively assisting these countries to man-
age problems of this kind, and this assistance makes
appropriate use ofthe scientific and technical capabilities
developed within the EC Environment R&D Programme.
This type of approach is also being established with
Mediterranean countries, within the framework of the
Community's International Scientific Cooperation
activities.
Theviews expressed in this paper are the author's and notnecessarily
those ofthe Commission ofthe European Communities.
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